Tirzepatide Safety Warning; Nurse Charged Over Fake GLP-1s; Revised Afrezza Dosing

By News Health
1 hour Ago

(MedPage Today) — Tirzepatide (Mounjaro, Zepbound) users should never share KwikPens due to risk for transmission of blood-borne pathogens, the FDA warned in an updated label.
GLP-1 medications for weight loss accounted for more than 7% of all…

Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/119607

Author :

Publish date : 2026-01-27 18:22:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Nixing Statins Pre-Pregnancy; Vascular Surgeon-Inventor Dies; Beta-Blocker in COPD?

Dual-Sensor Smartwatch May Boost Detection of Silent AF

Growing number of adults avoid booze, NHS survey suggests

Tailored Support Strategy May Increase Screening for Unhealthy Alcohol Use

Flu Season Is a Stress Test. Our Healthcare System Keeps Failing.

Our brains play a surprising role in recovering from a heart attack